The discovery of the first mRNA-stabilizing substance could pave the way for groundbreaking advancements in the development ...

Northwestern filed a lawsuit against Moderna Wednesday alleging the company misused the University’s patented lipid ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

Researchers are developing what they hope will be the first successful vaccine against the highly contagious and difficult-to ...

A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides ...

At IDWeek 2024, Moderna presented interim results from an ongoing Phase I/II dose-ranging trial for mRNA-1403, a vaccine ...

By Tarun Sai Lomte Groundbreaking study reveals new single-chain mRNA vaccines provide 100% protection against lethal mpox ...

He said: “The UK is leading the way to develop a world-first vaccine for this vomiting bug, starting with this innovative ...

In an era where viral outbreaks can escalate into global pandemics with alarming speed, the ability to quickly develop new ...

Revaccination at 12 months with the investigational respiratory syncytial virus (RSV) vaccine mRNA-1345 is well tolerated and supported for eligible older adults, according to study results presented ...

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...

高福院士/王奇慧团队基于结构生物学指导的疫苗研发平台，采用与新冠病毒重组蛋白亚单位疫苗相似的策略，创新性地设计出嵌合三价mRNA疫苗。该疫苗在小鼠中可诱导出高效的体液免疫与细胞免疫，维持抗体水平在免疫近6个月后基本不变，实现了致死剂量痘苗病毒攻毒后对 ...